The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

Henry Ford Health System in Detroit recently provided the first patient in Michigan — a 60-year-old man from the Cadillac ...

LAST weekend, a Filipina recounted her experience in a video after a beauty procedure where she underwent an intravenous (IV) glutathione procedure. That video has already gone viral and shows the ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic ...

A 60-year-old man from the Cadillac area has become the first patient in Michigan to receive a state-of-the-art aerosolized cancer treatment, performed by Henry Ford Health surgical oncologist Dr.

New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in ...

Knight and Helsinn had entered into an exclusive license, distribution and supply agreement for AKYNZEO ® oral/IV (netupitant/palonosetron / fosnetupitant/palonosetron) in Canada, Brazil, Argentina, ...

Oral paclitaxel matched IV in progression-free survival but outperformed it in overall survival for second-line advanced gastric cancer.

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

The Food and Drug Administration said Tuesday that no IV glutathione product in the Philippines was approved for skin whitening.

A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the cancer, may benefit ...